Cerevel Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CERE and other ETFs, options, and stocks.

About CERE

Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. 

CEO
N. Anthony Coles
CEON. Anthony Coles
Employees
200
Employees200
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2018
Founded2018
Employees
200
Employees200

CERE Key Statistics

Market cap
4.20B
Market cap4.20B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
723.95K
Average volume723.95K
High today
$27.83
High today$27.83
Low today
$26.41
Low today$26.41
Open price
$26.57
Open price$26.57
Volume
299.96K
Volume299.96K
52 Week high
$46.16
52 Week high$46.16
52 Week low
$19.86
52 Week low$19.86

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%

CERE Earnings

-$0.61
-$0.41
-$0.20
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, Pre-Market
ActualExpected Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.